Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients.

Ranganath VK, Duffy EL, Garg VK, Woodworth T, Taylor M, Paulus HE, Altman RD, Elashoff DA.

J Clin Rheumatol. 2018 Apr 16. doi: 10.1097/RHU.0000000000000799. [Epub ahead of print]

PMID:
29683839
2.

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.

Marchetti C, Swartzwelter B, Gamboni F, Neff CP, Richter K, Azam T, Carta S, Tengesdal I, Nemkov T, D'Alessandro A, Henry C, Jones GS, Goodrich SA, St Laurent JP, Jones TM, Scribner CL, Barrow RB, Altman RD, Skouras DB, Gattorno M, Grau V, Janciauskiene S, Rubartelli A, Joosten LAB, Dinarello CA.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1530-E1539. doi: 10.1073/pnas.1716095115. Epub 2018 Jan 29.

3.

Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis.

Altman RD, Dasa V, Takeuchi J.

Cartilage. 2018 Jan;9(1):11-20. doi: 10.1177/1947603516684588. Epub 2016 Dec 29.

4.

Letter to the Editor on "The AAHKS Clinical Research Award: What Are the Costs of Knee Osteoarthritis in the Year Prior to Total Knee Arthroplasty?"

Altman RD.

J Arthroplasty. 2018 Jan;33(1):305-306. doi: 10.1016/j.arth.2017.10.003. Epub 2017 Oct 10. No abstract available.

PMID:
29066247
5.

Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice.

Cooper C, Rannou F, Richette P, Bruyère O, Al-Daghri N, Altman RD, Brandi ML, Collaud Basset S, Herrero-Beaumont G, Migliore A, Pavelka K, Uebelhart D, Reginster JY.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1287-1296. doi: 10.1002/acr.23204. Epub 2017 Aug 8. Review. No abstract available.

6.

Response to Letter to the Editor on 'Hyaluronic Acid Injections in Medicare Knee Osteoarthritis Patients Are Associated With Longer Time to Knee Arthroplasty'.

Ong KL, Anderson AF, Niazi F, Kurtz SM, Altman RD.

J Arthroplasty. 2017 Feb;32(2):697-698. doi: 10.1016/j.arth.2016.08.043. Epub 2016 Sep 30. No abstract available.

PMID:
27780626
7.

Unraveling the confusion behind hyaluronic acid efficacy in the treatment of symptomatic knee osteoarthritis.

Miller LE, Altman RD, McIntyre LF.

J Pain Res. 2016 Jun 17;9:421-3. doi: 10.2147/JPR.S110675. eCollection 2016.

8.

Analysis for Prognostic Factors from a Database for the Intra-Articular Hyaluronic Acid (Euflexxa) Treatment for Osteoarthritis of the Knee.

Altman RD, Farrokhyar F, Fierlinger A, Niazi F, Rosen J.

Cartilage. 2016 Jul;7(3):229-37. doi: 10.1177/1947603515620890. Epub 2015 Dec 13.

9.

Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials.

Altman RD, Devji T, Bhandari M, Fierlinger A, Niazi F, Christensen R.

Semin Arthritis Rheum. 2016 Oct;46(2):151-9. doi: 10.1016/j.semarthrit.2016.04.003. Epub 2016 Apr 27. Review.

10.

Exploring reasons for the observed inconsistent trial reports on intra-articular injections with hyaluronic acid in the treatment of osteoarthritis: Meta-regression analyses of randomized trials.

Johansen M, Bahrt H, Altman RD, Bartels EM, Juhl CB, Bliddal H, Lund H, Christensen R.

Semin Arthritis Rheum. 2016 Aug;46(1):34-48. doi: 10.1016/j.semarthrit.2016.02.010. Epub 2016 Mar 8. Review.

PMID:
27139169
11.

Hyaluronic Acid Injections in Medicare Knee Osteoarthritis Patients Are Associated With Longer Time to Knee Arthroplasty.

Ong KL, Anderson AF, Niazi F, Fierlinger AL, Kurtz SM, Altman RD.

J Arthroplasty. 2016 Aug;31(8):1667-73. doi: 10.1016/j.arth.2016.01.038. Epub 2016 Jan 29.

PMID:
26895820
12.

A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting.

Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, Martel-Pelletier J, Reginster JY.

Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S3-11. doi: 10.1016/j.semarthrit.2015.11.010. Epub 2015 Dec 2.

13.

Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.

Bruyère O, Altman RD, Reginster JY.

Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S12-7. doi: 10.1016/j.semarthrit.2015.11.011. Epub 2015 Dec 2. Review.

14.

Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee.

Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E.

Am J Sports Med. 2016 Aug;44(8):2158-65. doi: 10.1177/0363546515609599. Epub 2015 Nov 17. Review.

PMID:
26578719
15.

The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review.

Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M.

BMC Musculoskelet Disord. 2015 Oct 26;16:321. doi: 10.1186/s12891-015-0775-z. Review.

16.

Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid.

Altman RD, Schemitsch E, Bedi A.

Semin Arthritis Rheum. 2015 Oct;45(2):132-9. doi: 10.1016/j.semarthrit.2015.04.013. Epub 2015 May 7. Review.

17.

RS3PE: Clinical and Research Development.

Li H, Altman RD, Yao Q.

Curr Rheumatol Rep. 2015 Aug;17(8):49. doi: 10.1007/s11926-015-0525-0. Review.

PMID:
26113011
18.

OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.

Hunter DJ, Altman RD, Cicuttini F, Crema MD, Duryea J, Eckstein F, Guermazi A, Kijowski R, Link TM, Martel-Pelletier J, Miller CG, Mosher TJ, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Raynauld JP, Roemer FW, Totterman SM, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):698-715. doi: 10.1016/j.joca.2015.03.012. Review. Erratum in: Osteoarthritis Cartilage. 2015 Aug; 23(8):1434-5.

19.

Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.

Altman RD, Strand V, Hochberg MC, Gibofsky A, Markenson JA, Hopkins WE, Cryer B, Kivitz A, Nezzer J, Imasogie O, Young CL.

Postgrad Med. 2015 Jun;127(5):517-28. doi: 10.1080/00325481.2015.1040716. Epub 2015 Apr 27.

PMID:
25913498
20.

Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials.

Bartels EM, Folmer VN, Bliddal H, Altman RD, Juhl C, Tarp S, Zhang W, Christensen R.

Osteoarthritis Cartilage. 2015 Jan;23(1):13-21. doi: 10.1016/j.joca.2014.09.024. Epub 2014 Oct 7.

21.

Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.

Eriksen P, Bartels EM, Altman RD, Bliddal H, Juhl C, Christensen R.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1844-55. doi: 10.1002/acr.22376.

22.

Cost-effectiveness analysis of intra-articular injections of a high molecular weight bioengineered hyaluronic acid for the treatment of osteoarthritis knee pain.

Hatoum HT, Fierlinger AL, Lin SJ, Altman RD.

J Med Econ. 2014 May;17(5):326-37. doi: 10.3111/13696998.2014.902843. Epub 2014 Mar 21.

PMID:
24625229
23.

A phase 2 study of lower-dose, indomethacin submicron particle capsules demonstrates early onset of acute pain relief.

Manvelian G, Hochberg MC, Daniels SE, Altman RD, Young CL.

Clin J Pain. 2014 Oct;30(10):846-51. doi: 10.1097/AJP.0000000000000053.

PMID:
24300220
24.

A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis.

Arden NK, Åkermark C, Andersson M, Todman MG, Altman RD.

Curr Med Res Opin. 2014 Feb;30(2):279-86. doi: 10.1185/03007995.2013.855631. Epub 2013 Nov 5.

PMID:
24168077
25.

Thiopurine methyltransferase measurement may not predict azathiopurine-associated non-myelotoxicity.

Yao Q, Altman RD.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):156. Epub 2012 Nov 28. No abstract available.

PMID:
23192017
26.

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P; American College of Rheumatology.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74. Review.

PMID:
22563589
27.

Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis.

Yao Q, Altman RD, Wang X.

J Clin Rheumatol. 2012 Jan;18(1):28-32. doi: 10.1097/RHU.0b013e31823ecbdf. Review.

PMID:
22157271
28.

Pharmacologic treatment of knee osteoarthritis in athletic women.

Altman RD, Fowler PJ.

Phys Sportsmed. 2011 Sep;39(3):39-44. doi: 10.3810/psm.2011.09.1919. Review.

PMID:
22030939
29.

Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study.

Altman RD, Lang AE, Postuma RB.

Mov Disord. 2011 Nov;26(13):2427-31. doi: 10.1002/mds.23873. Epub 2011 Sep 27.

PMID:
21953603
30.

Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial.

Altman RD, Rosen JE, Bloch DA, Hatoum HT.

Osteoarthritis Cartilage. 2011 Oct;19(10):1169-75. doi: 10.1016/j.joca.2011.07.001. Epub 2011 Jul 23.

31.

Topical therapies for osteoarthritis.

Altman RD, Barthel HR.

Drugs. 2011 Jul 9;71(10):1259-79. doi: 10.2165/11592550-000000000-00000. Review.

PMID:
21770475
32.

Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment.

Mease PJ, Hanna S, Frakes EP, Altman RD.

J Rheumatol. 2011 Aug;38(8):1546-51. doi: 10.3899/jrheum.100759. Epub 2011 Jun 1. Review.

PMID:
21632678
33.

Safety advantages of topical versus oral nonsteroidal antiinflammatory drugs.

Altman RD.

J Rheumatol. 2011 Mar;38(3):572; author reply 573. doi: 10.3899/jrheum.100748. No abstract available.

PMID:
21362791
34.
35.

Opioid therapy for osteoarthritis and chronic low back pain.

Altman RD, Smith HS.

Postgrad Med. 2010 Nov;122(6):87-97. doi: 10.3810/pgm.2010.11.2226. Review.

PMID:
21084785
36.

New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm.

Altman RD.

Curr Med Res Opin. 2010 Dec;26(12):2871-6. doi: 10.1185/03007995.2010.533650. Epub 2010 Nov 11. Review.

PMID:
21070097
37.

Glucosamine and osteoarthritis. Prescribed regimen is effective.

Reginster JY, Altman RD, Hochberg MC.

BMJ. 2010 Nov 9;341:c6335. doi: 10.1136/bmj.c6335. No abstract available.

PMID:
21062885
38.

Heritability patterns in hand osteoarthritis: the role of osteophytes.

Ishimori ML, Altman RD, Cohen MJ, Cui J, Guo X, Rotter JI, Weisman MH.

Arthritis Res Ther. 2010;12(5):R180. doi: 10.1186/ar3144. Epub 2010 Sep 28.

39.

Pharmacological therapies for osteoarthritis of the hand: a review of the evidence.

Altman RD.

Drugs Aging. 2010 Sep 1;27(9):729-45. doi: 10.2165/11539010-000000000-00000. Review.

PMID:
20809663
40.

Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial.

Baraf HS, Gold MS, Clark MB, Altman RD.

Phys Sportsmed. 2010 Jun;38(2):19-28. doi: 10.3810/psm.2010.06.1779.

PMID:
20631460
41.

Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee.

Altman RD.

Expert Rev Clin Immunol. 2010 Jan;6(1):21-7. Review.

PMID:
20383887
42.

Early management of osteoarthritis.

Altman RD.

Am J Manag Care. 2010 Mar;16 Suppl Management:S41-7. Review.

43.

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P.

Osteoarthritis Cartilage. 2010 Apr;18(4):476-99. doi: 10.1016/j.joca.2010.01.013. Epub 2010 Feb 11. Review.

44.

Response to Kroenke, Krebs and Bair.

Altman RD.

Gen Hosp Psychiatry. 2010 Jan-Feb;32(1):111-2; author reply 112-3. doi: 10.1016/j.genhosppsych.2009.09.004. Epub 2009 Oct 28. No abstract available.

PMID:
20114139
45.

Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.

Barthel HR, Peniston JH, Clark MB, Gold MS, Altman RD.

Arthritis Res Ther. 2010;12(1):R7. doi: 10.1186/ar2906. Epub 2010 Jan 11.

46.

Introduction to Cartilage.

Altman RD.

Cartilage. 2010 Jan;1(1):5. doi: 10.1177/1947603509345128. No abstract available.

47.

Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis.

Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD.

Semin Arthritis Rheum. 2009 Dec;39(3):203-12. doi: 10.1016/j.semarthrit.2009.09.002. Erratum in: Semin Arthritis Rheum. 2010 Aug;40(1):95.

PMID:
19932833
48.

Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials.

Bartels EM, Bliddal H, Schøndorff PK, Altman RD, Zhang W, Christensen R.

Osteoarthritis Cartilage. 2010 Mar;18(3):289-96. doi: 10.1016/j.joca.2009.10.006. Epub 2009 Oct 14.

49.

Practical considerations for the pharmacologic management of osteoarthritis.

Altman RD.

Am J Manag Care. 2009 Sep;15(8 Suppl):S236-43.

50.

Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial.

Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J.

J Rheumatol. 2009 Sep;36(9):1991-9. doi: 10.3899/jrheum.081316. Epub 2009 Jul 31.

PMID:
19648310

Supplemental Content

Loading ...
Support Center